sites

Support rapid case processing and regulatory reporting

Facilitate data reconciliation with EDC/CTMS systems

Provide audit-ready documentation and traceability

Many sponsors use platforms like ARISg, Argus, Veeva Vault Safety, or Oracle AERS, all of which can be customized with SOP-aligned workflows. You can also integrate these databases with systems recommended by StabilityStudies.in for streamlined documentation.

Step-by-Step Guide to SAE Tracking in Safety Databases:

1. Case Intake and SAE Entry:

As soon as an SAE form is received from the site, safety staff must:

• Create a new case record in the safety database
• Enter key data: subject ID, event term, event start date, causality, and outcome
• Attach relevant documents (lab reports, discharge summaries)

2. MedDRA Coding:

All event terms must be coded using MedDRA (Medical Dictionary for Regulatory Activities) to enable standardization and analysis. Use appropriate hierarchy (LLT → PT → SOC) during coding.

3. Case Validation:

Each SAE case is reviewed for completeness and quality. Common validation checks include:

• Presence of seriousness criteria
• Causality assigned by investigator
• Expectedness assessment vs IB/SmPC
• Supporting documents uploaded

4. Expedited Reporting Timelines:

Event Type	Timeline	Reported To
Fatal or Life-Threatening SUSAR	Within 7 calendar days	Regulatory authority
Non-Fatal SUSAR	Within 15 calendar days	Regulatory authority
Expected SAE	Included in DSUR	Regulatory authority

The system should generate auto-alerts and submission logs for each reportable case.

5. Follow-Up Data Management:

Ongoing SAE cases often require updates. The safety database should:

• Generate reminders for pending follow-ups
• Allow updating outcomes, narratives, and additional test results
• Link follow-up entries to the parent case ID

6. SAE Reconciliation:

Sponsors must reconcile SAE data between the safety database and clinical EDC database at regular intervals. Use tools within the system to:

• Match subject IDs, event dates, and MedDRA terms
• Identify missing cases or discrepancies
• Generate reconciliation reports for QA

Platforms such as Pharma SOP templates offer reconciliation checklists that streamline this process.

Best Practices for Safety Database Usage:

1. Validate the database per GAMP 5 and 21 CFR Part 11 requirements
2. Train all pharmacovigilance staff in consistent data entry and coding
3. Use SOPs to guide case processing timelines and responsibilities
4. Restrict database access based on roles
5. Back up data regularly and conduct audit trail reviews

Common Pitfalls and How to Avoid Them:

• Inconsistent coding: Use controlled MedDRA versions and training to standardize entries
• Delayed data entry: Automate alerts for overdue SAE cases
• Duplicate records: Use system logic to detect and merge duplicates
• Incomplete narratives: Include narrative templates and QA reviews before finalization

Regulatory Expectations:

Health authorities expect sponsors to maintain audit-ready safety databases with timely SAE reporting. As per ICH and GMP compliance standards, systems should be secure, validated, and backed by SOPs.

Training and Oversight:

• Maintain training logs for all database users
• Conduct regular refresher sessions on coding, reporting, and reconciliation
• Monitor compliance using dashboards and audit logs

Conclusion:

Safety databases are indispensable tools for SAE tracking in clinical trials. When used correctly, they provide a centralized, compliant, and efficient way to manage adverse event data and fulfill global regulatory obligations. By following structured workflows, maintaining validated systems, and integrating with clinical operations, organizations can uphold the highest standards of patient safety and trial integrity.